Carmine Therapeutics

Developer of gene-based therapies using blood cell vesicle-based drug delivery systems

placeSingapore, Singapore, Singapore calendar_todayFounded 2019 groups33 employees language carminetherapeutics.com

Registered entities

Investor mix

9 investors on record; lead investors include Huagai Capital.

Investor typeCountShare
Venture capital222%
Private equity111%
Other / undisclosed667%
Coming soon